Key result
Patients with severe COVID-19 had impaired left ventricular global longitudinal strain and lower left ventricular ejection fraction compared to those with nonsevere COVID-19.
Why the study?
The study was designed to investigate the cardiac manifestations of COVID-19.
Cohort (n=40)
Yes
Severe COVID-19 is associated with subclinical left ventricular dysfunction as evidenced by reduced LVEF and impaired global longitudinal strain.
Answers are grounded in this paper and cite their sources.
May support cardiac monitoring in severe COVID-19; leaves open whether strain imaging improves outcomes.
Background: This study aimed to investigate the cardiac manifestations of coronavirus disease 2019 (COVID-19). Methods: From February to March 2020, we prospectively and retrospectively enrolled consecutive patients diagnosed with COVID-19. Patient's data such as the demographic characteristics, symptoms, vital signs, laboratory and radiologic findings, electrocardiographic, and echocardiographic data, including the global longitudinal strain (GLS) of both ventricles, were obtained. Results: Forty patients (median age, 58 years; 50% men) were enrolled in the initial analysis. Patients were classified into severe and nonsevere groups based on the current guidelines. The 13 patients in the severe group were significantly older, had a greater prevalence of bilateral pneumonia and leukocytosis, and higher aspartate transaminase levels than patients in the nonsevere group. Patients in the severe group had a slightly lower left ventricular ejection fraction (LVEF) than those in the nonsevere group (median [interquartile range], 61.0% [58.5%, 62.3%] vs. 66.7% [60.6%, 69.8%], P = 0.015). In a subgroup of 34 patients in whom GLS could be analyzed, patients in the severe group had a significantly impaired left ventricular GLS (LVGLS) than those in the nonsevere group (-18.1% [-18.8%, -17.1%] vs. -21.7% [-22.9%, -1 9.9%], P = 0.001). There were no significant differences in total wall (RVGLS total , -19.3% [-23.9%, -18.4%] vs. -24.3% [-26.0%, -22.6%], P = 0.060) and free wall (RVGLS fw , -22.7% [-27.2%, -18.6%] vs. -28.8% [-30.4%, -24.1%], P = 0.066) right ventricle GLS (RVGLS). Conclusion: Patients with severe COVID-19 had lower LVEF and LVGLS. RVGLS was not different between patients with severe and nonsevere COVID-19.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted a cohort in COVID-19 (n=40). Severe COVID-19 vs. Nonsevere COVID-19 was evaluated on Left ventricular global longitudinal strain (LVGLS) (p=0.001). Patients with severe COVID-19 had impaired left ventricular global longitudinal strain and lower left ventricular ejection fraction compared to those with nonsevere COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: